首页行业分类生物医药生物2023-03-30-西南证券-康华生物-主业稳健增长,23年放量可期
PDF

2023-03-30-西南证券-康华生物-主业稳健增长,23年放量可期

w*******m4页1.12M

下载文档
/4
全屏查看
2023-03-30-西南证券-康华生物-主业稳健增长,23年放量可期
还有 4 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 4 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
康单生物(300841)2022年年报点评2022A2023E2024E2025E2022A2023E2024E2025E1446.722047.032958.983310.72598.07838.141205.551313.81营业成本93.13138.91227.30289.13折旧与摊销39.9136.0236.0236.02营业税金及册加8.2311.7916.8618.93-10.970.050.090.08销售货用428.12614.11858.11927.00-8.710.000.000.0082.66133.06186.42201.95经营营运黄本变动-331.2122.12-512.9789.93财务货用-10.970.050.090.08其他-92.101.121.83-0.82-8710.000.000.00194.99853.22730.521259.175.010.000.000.00.498.510.000.000.0051.890.000.000.0086.050.000.000.00其他经营损益0.000.000.000.00-412.460.000.000.00685.501016.051448.291575.66短期借款109.30109.300.000.00-1.71-30.00-30.00-30.0015.750.000.000.00683.79986.051418.291545.668.2915.000.000.00所得税85.73147.91212.74231.85支付股利-133.78-119.61-167.63-241.11598.07838.141205.551313.8173.12.1.36-0.09-0.080.000.000.000.00-73.56-215.27.167.71-241.19598.07838.141205.551313.81-290.92637.95562.811017.982022A2023E2024E2025E2022A2023E2024E2025E651.461289.411852.222870.20成长能力应收和预付款项1339.991517.692348.072654.0611.94%41.49%44.55%11.89%存货153.65228.72372.99475.83-25.14%48.22%42.54%8.79%其他流动黄产0.000.000.000.00-27.90%40.14%43.84%8.98%0.000.000.000.00BTDA增长率-21.91%47.27%41.09%8.58%0.000.000.000.00985.00968.72932.43906.15毛利率93.56%93.21%92.32%91.27%无彩资产和开发支出17.2312.878.514.1434.55%36.50%35.30%34.10%563.73558.35552.98547.6041.34%40.94%40.74%39.68%3711.074565.776067.197457.98ROE19.45%22.00%24.87%22.19%109.300.000.000.00ROA16.12%18.36%19.87%17.62%85.67113.60183.06225.52ROIC33.47%39.07%48.83%46.91%长期借款15.7515.7515.7515.7549.38%51.40%50.17%48.68%424.68627.231021.271296.89635.40756.581220.081538.170.430.490.560.49股本134.65134.65134.65134.654.074.567.018.361183.501198.501198.501198.501.361.491.591.38留存收益1880.612599.143637.064709.76存货周转率0.720.730.750.683075.673809.194847.115919.8169.63%0.000.000.000.003075.673809.194847.115919.8117.12%16.57%20.11%20.62%3711.074565.776067.197457.98带息债务感负债19.68%2.08%1.29%1.02%流动比率3.514.143.823.962022A2023E2024E2025E速动比率3.263.833.513.65EBITDA714.441052.121484.401611.77股利支付率22.37%14.27%13.90%18.35%PE21.7715.5410.809.914.233.422.692.204.446.228.959.76PS9.006.364.403.9322.8428.2936.0043.96EV/EBITDA16.7810.687.195.99每股经营现金1.456.345.439.351.03%0.92%1.29%1.85%每股股利0.990.891.241.79请务必阅读正文后的重要声明部分